Osaic Holdings’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $131K | Buy |
12,356
+8,944
| +262% | +$94.7K | ﹤0.01% | 3953 |
|
2025
Q1 | $42.9K | Sell |
3,412
-8,936
| -72% | -$112K | ﹤0.01% | 4816 |
|
2024
Q4 | $130K | Buy |
12,348
+9,896
| +404% | +$104K | ﹤0.01% | 3975 |
|
2024
Q3 | $35.6K | Buy |
2,452
+2,344
| +2,170% | +$34K | ﹤0.01% | 4960 |
|
2024
Q2 | $918 | Sell |
108
-656
| -86% | -$5.58K | ﹤0.01% | 6650 |
|
2024
Q1 | $7.81K | Buy |
764
+91
| +14% | +$930 | ﹤0.01% | 5803 |
|
2023
Q4 | $3.69K | Buy |
+673
| New | +$3.69K | ﹤0.01% | 6198 |
|
2023
Q1 | – | Sell |
-2,000
| Closed | -$17K | – | 7406 |
|
2022
Q4 | $17K | Hold |
2,000
| – | – | ﹤0.01% | 5666 |
|
2022
Q3 | $11K | Buy |
+2,000
| New | +$11K | ﹤0.01% | 5951 |
|